Biography:
Sophie Sall studied cellular and molecular biology at Towson University in Towson Maryland and graduated with a Bachelor of Science with honors in 2021. Since graduation she has joined the Laterra Lab at Johns Hopkins School of Medicine and Kennedy Krieger Research Institute researching the molecular characteristics of glioblastoma and the driving forces behind treatment resistance, tumor recurrence, and the glioma stem cell phenotype under the supervision of Dr. Lopez-Bertoni and Dr. Laterra.
Title : miR-590-3p delivery via nanoparticle technology inhibits recurrent GBM tumor growth by targeting multiple oncogenic nodes downstream of TGFBR2